Clinical trial
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects Under Feed Conditions.
NCT07763964 is registered in ClinicalTrials.gov with ADIUM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects Under Feed Conditions.
- Lead sponsor
- ADIUM
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 8, 2025
- Completion date
- December 19, 2025
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bioequivalance